Not Yet Recruiting Tumor Budding and T1 Substaging in Urothelial Bladder Cancer NCT07529639 Conditions Bladder Carcinoma, Carcinoma, Disease Attributes, +20 more Locations Not specified View Trial Details
Completed Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma NCT02736266 Conditions Urothelial Bladder Carcinoma Locations Fondazione IRCCS Istituto Nazionale dei Tumori — Milan, Mi, Italy View Trial Details
Active, Not Recruiting PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer NCT06133517 Conditions Urothelial Bladder Carcinoma Locations Hospital Duran i Reynals (ICO L´Hospitalet) — L'Hospitalet de Llobregat, Barcelona, Spain Hospital Universitario Marqués de Valdecilla — Santander, Cantabria, Spain Hospital Clínico San Carlos — Madrid, Spain Hospital Universitario de Navarra — Pamplona, Navarre, Spain View more locations Show fewer locations Loading locations... View Trial Details
